Avicanna Inc. (OTCMKTS:AVCNF) Sees Significant Increase in Short Interest

Avicanna Inc. (OTCMKTS:AVCNF) was the recipient of a significant increase in short interest during the month of June. As of June 30th, there was short interest totaling 205,778 shares, an increase of 402.1% from the June 15th total of 40,987 shares. Based on an average daily volume of 158,451 shares, the days-to-cover ratio is presently 1.3 days.

Avicanna Price Performance

Avicanna stock opened at $0.10 on Monday. The stock has a 50-day moving average price of $0.09 and a 200 day moving average price of $0.12. Avicanna has a 52 week low of $0.07 and a 52 week high of $0.24.

About Avicanna

Avicanna Inc, a commercial-stage biopharmaceutical company, engages in the research, development, advancement, and commercialization of evidence-based cannabinoid-based products and formulations for consumer, medical, and pharmaceutical markets worldwide. It commercializes approximately thirty proprietary evidence-based finished products. The company provides medical cannabis formulary products, including oral, sublingual, topical, and transdermal deliveries with various ratios of cannabinoids under the RHO Phyto brand; and indication-specific pharmaceutical products to address unmet medical needs in the areas of dermatology, chronic pain, and various neurological disorders, such as Trunerox, an adjuvant treatment for seizures associated with Lennox-Gastaut Syndrome and Dravet Syndrome.